Shopping Cart 0
Cart Subtotal
USD 0

APR Applied Pharma Research SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

APR Applied Pharma Research SA (APR) is a healthcare product developer and distributor. The company research, develops, and licenses technology and clinically proven prescription pharmaceuticals. It offers consumer health products, prescription healthcare products and therapeutic products. APR's product pipeline portfolio includes nexodyn, gemiax, exelya, APR 1301-01, APR 1203-01 and APR 1204. The company offers services such as oral formulations, tropical formulations and analytical services. It develops products for various therapeutic areas including cancer, dermatology, genetic metabolic diseases, pain management and tissue transplantation APR is headquartered in Balerna, Switzerland.

APR Applied Pharma Research SA-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

APR Applied Pharma Research Raises Funds through Venture Financing 11

Private Equity 12

HBM Partners Acquires Minority Stake in APR Applied Pharma 12

Partnerships 13

APR Applied Pharma Research Enter into Distribution Agreement with Aghraas-Cigalah 13

Fidia Farmaceutici Enters into Agreement with APR Applied Pharma Research 14

Licensing Agreements 15

Mundipharma Enters into Licensing Agreement with APR Applied Pharma Research 15

Renhe Enters into Licensing Agreement with APR Applied Pharma Research for Diclofenac Powder 16

APR Applied Pharma Research And Labtec Enter Into Licensing Agreement With Norgine For Setofilm 17

Eris Pharma Enters into Licensing Agreement with APR Applied Pharma Research 18

APR Applied Pharma Enters into Licensing Agreement with Amicus 19

Angelini Enters Into Licensing Agreement With APR Applied Pharma 20

APR Applied Pharma Research SA-Key Competitors 21

APR Applied Pharma Research SA-Key Employees 22

APR Applied Pharma Research SA-Locations And Subsidiaries 23

Head Office 23

Recent Developments 24

Product News 24

Sep 05, 2017: PKU: Pre-Clinical Kinetic Data Showing Prolonged Release of Amino Acids Thanks to the Innovative Physiomimic Technology by APR Presented at the 13th ICIEM Congress (September 5th-8th, Rio de Janeiro) 24

Apr 06, 2017: APR Applied Pharma Research Wants to Make the Difference for PKU People Thanks to an Innovative and Patented Technology 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 26


List Of Figure

List of Figures

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Key Facts 2

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

APR Applied Pharma Research SA, Deals By Therapy Area, 2012 to YTD 2018 8

APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

APR Applied Pharma Research Raises Funds through Venture Financing 11

HBM Partners Acquires Minority Stake in APR Applied Pharma 12

APR Applied Pharma Research Enter into Distribution Agreement with Aghraas-Cigalah 13

Fidia Farmaceutici Enters into Agreement with APR Applied Pharma Research 14

Mundipharma Enters into Licensing Agreement with APR Applied Pharma Research 15

Renhe Enters into Licensing Agreement with APR Applied Pharma Research for Diclofenac Powder 16

APR Applied Pharma Research And Labtec Enter Into Licensing Agreement With Norgine For Setofilm 17

Eris Pharma Enters into Licensing Agreement with APR Applied Pharma Research 18

APR Applied Pharma Enters into Licensing Agreement with Amicus 19

Angelini Enters Into Licensing Agreement With APR Applied Pharma 20

APR Applied Pharma Research SA, Key Competitors 21

APR Applied Pharma Research SA, Key Employees 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

APR Applied Pharma Research SA (APR) is a healthcare product developer and distributor. The company research, develops, and licenses technology and clinically proven prescription pharmaceuticals. It offers consumer health products, prescription healthcare products and therapeutic products. APR's product pipeline portfolio includes nexodyn, gemiax, exelya, APR 1301-01, APR 1203-01 and APR 1204. The company offers services such as oral formulations, tropical formulations and analytical services. It develops products for various therapeutic areas including cancer, dermatology, genetic metabolic diseases, pain management and tissue transplantation APR is headquartered in Balerna, Switzerland.

APR Applied Pharma Research SA-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

APR Applied Pharma Research Raises Funds through Venture Financing 11

Private Equity 12

HBM Partners Acquires Minority Stake in APR Applied Pharma 12

Partnerships 13

APR Applied Pharma Research Enter into Distribution Agreement with Aghraas-Cigalah 13

Fidia Farmaceutici Enters into Agreement with APR Applied Pharma Research 14

Licensing Agreements 15

Mundipharma Enters into Licensing Agreement with APR Applied Pharma Research 15

Renhe Enters into Licensing Agreement with APR Applied Pharma Research for Diclofenac Powder 16

APR Applied Pharma Research And Labtec Enter Into Licensing Agreement With Norgine For Setofilm 17

Eris Pharma Enters into Licensing Agreement with APR Applied Pharma Research 18

APR Applied Pharma Enters into Licensing Agreement with Amicus 19

Angelini Enters Into Licensing Agreement With APR Applied Pharma 20

APR Applied Pharma Research SA-Key Competitors 21

APR Applied Pharma Research SA-Key Employees 22

APR Applied Pharma Research SA-Locations And Subsidiaries 23

Head Office 23

Recent Developments 24

Product News 24

Sep 05, 2017: PKU: Pre-Clinical Kinetic Data Showing Prolonged Release of Amino Acids Thanks to the Innovative Physiomimic Technology by APR Presented at the 13th ICIEM Congress (September 5th-8th, Rio de Janeiro) 24

Apr 06, 2017: APR Applied Pharma Research Wants to Make the Difference for PKU People Thanks to an Innovative and Patented Technology 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 26


List Of Figure

List of Figures

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Key Facts 2

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

APR Applied Pharma Research SA, Deals By Therapy Area, 2012 to YTD 2018 8

APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9

APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

APR Applied Pharma Research Raises Funds through Venture Financing 11

HBM Partners Acquires Minority Stake in APR Applied Pharma 12

APR Applied Pharma Research Enter into Distribution Agreement with Aghraas-Cigalah 13

Fidia Farmaceutici Enters into Agreement with APR Applied Pharma Research 14

Mundipharma Enters into Licensing Agreement with APR Applied Pharma Research 15

Renhe Enters into Licensing Agreement with APR Applied Pharma Research for Diclofenac Powder 16

APR Applied Pharma Research And Labtec Enter Into Licensing Agreement With Norgine For Setofilm 17

Eris Pharma Enters into Licensing Agreement with APR Applied Pharma Research 18

APR Applied Pharma Enters into Licensing Agreement with Amicus 19

Angelini Enters Into Licensing Agreement With APR Applied Pharma 20

APR Applied Pharma Research SA, Key Competitors 21

APR Applied Pharma Research SA, Key Employees 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS